School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Telix Pharmaceuticals Limited TLX

Healthcare · Biotechnology

$10.92last close 2026-10-13 · market cap $3.70B · delayed data

Trailing returns

1M-3.28%
3M-0.46%
6M-2.85%
1Y+14.47%

Basis: Adjusted daily closes.

What it does

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions.

Open TLX in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies